Biatain® Silicone Ag is an antimicrobial silver foam dressing designed for exuding wounds with signs and symptoms of local infection, suspected biofilm, or increased risk of wound infection.
The dressing combines a conformable polyurethane foam with a silicone adhesive border and a semi-permeable, water- and bacteria-proof outer film. It incorporates ionic silver for sustained antimicrobial activity while helping manage wound exudate and maintain close contact with the wound bed.
Biatain Silicone Ag is classified as an antimicrobial silver foam dressing. It consists of a conformable polyurethane foam with a silicone adhesive border and a semi-permeable protective top film.
The dressing contains a patented ionic silver complex designed to provide sustained-release, broad-spectrum antimicrobial activity for up to 7 days.
In-vitro testing has demonstrated that Biatain Ag can kill mature biofilms and help prevent biofilm formation.
Biatain Silicone Ag combines exudate management, wound-bed conformity, and antimicrobial silver within a single bordered foam dressing.
Biatain Silicone Ag incorporates 3DFit® Technology, allowing the dressing to fully conform to wound depths of up to approximately 2 cm.
This close conformity allows the dressing to function as a primary cover dressing for wounds with a visible wound bed. By minimizing dead space between the dressing and wound surface, the dressing helps reduce areas where exudate could otherwise pool.
The dressing is packaged using a three-piece no-touch opening system designed to support aseptic and easy application.
Biatain Silicone Ag may be used for exuding wounds where antimicrobial management is clinically appropriate.
The dressing is indicated for exuding wounds demonstrating signs and symptoms of local wound infection.
Biatain Silicone Ag may also be used in exuding wounds where biofilm is suspected. Its silver-containing foam has demonstrated activity against mature biofilms and prevention of biofilm formation in laboratory testing.
The dressing may be used prophylactically in patients considered at high risk for developing a wound infection.
Biatain Silicone Ag may be used in conjunction with compression therapy when compression forms part of the patient’s wound-management plan.
| Category | Clinical Considerations |
|---|---|
| Silver Sensitivity or Allergy | Do not use in patients with known sensitivity or allergy to silver. |
| Oxidizing Solutions | Do not use with oxidizing solutions such as hypochlorite or hydrogen peroxide solutions. |
| Barrier Film | Barrier film wipes or sprays should not be used with Biatain Silicone Ag or other silicone-bordered dressings. |
| Pregnancy & Lactation | Use during pregnancy or lactation has not been demonstrated. |
| Pediatric Use | Use in children has not been demonstrated. |
| Enzymatic Debridement | Use with enzymatic debriding agents has not been demonstrated. |
| Electrical Electrodes | Avoid placing electrodes or conductive gels in direct contact with silver products. |
| Radiation & Imaging | Remove before radiation treatment or examinations involving X-rays, including CT scanning, and before ultrasonic treatment, diathermy, or microwave therapy. |
| MRI | The dressing may remain in place during MRI. |
| Wound-Bed Discoloration | The dressing may cause transient discoloration of the wound bed. |
Biatain Silicone Ag is available in several dressing sizes:
Cleanse or irrigate the wound and surrounding periwound skin using normal saline or sterile water.
Cleansing helps reduce wound debris. The safe use of other cleansing agents with the dressing has not been demonstrated.
Thoroughly dry the surrounding skin before applying the dressing. Properly dried periwound skin helps promote effective adhesion of the silicone-bordered dressing.
If creams, ointments, or similar products have been applied to the periwound skin, allow the skin to dry before placing the dressing.
Do not use barrier film wipes or sprays on the periwound skin before applying Biatain Silicone Ag.
Select a dressing where the foam pad extends at least 2 cm beyond the wound edge.
For small wounds, approximately 1 cm of overlap beyond the wound edge is sufficient.
Correct sizing is important because inappropriate dressing size may adversely affect dressing function.
If the wound is producing only a small amount of exudate, the foam may be moistened with sterile normal saline before being placed over the wound.
If Biatain Silicone Ag adheres to the wound bed, reassess whether the wound is producing enough exudate to warrant continued use of the dressing.
A wound producing insufficient moisture may not be well matched to an absorbent foam dressing.
Biatain Silicone Ag should be changed when clinically indicated or at least every 7 days.
An earlier dressing change is indicated when visible wound exudate begins approaching the edge of the dressing.
When Biatain Silicone Ag is being used to manage a wound with local infection, the expected outcome is resolution of signs and symptoms of local wound infection within approximately 2 weeks.
When used prophylactically in a patient considered at high risk for infection, the expected outcome is that a local wound infection does not develop.
| Dressing Classification | Antimicrobial silver foam |
| Dressing Material | Conformable polyurethane foam |
| Border | Silicone adhesive border |
| Outer Layer | Semi-permeable water- and bacteria-proof top film |
| Antimicrobial Agent | Patented ionic silver complex |
| Antimicrobial Duration | Up to 7 days |
| Biofilm Activity | Demonstrated in vitro against mature biofilm and biofilm formation |
| Technology | 3DFit Technology |
| Wound Depth | Designed to conform to wounds up to approximately 2 cm deep |
| Primary Indication | Exuding wounds with local infection, suspected biofilm, or increased infection risk |
| Compression Therapy | May be used in conjunction with compression therapy |
| Recommended Overlap | At least 2 cm; approximately 1 cm for small wounds |
| Maximum Dressing Interval | Up to 7 days, or sooner when clinically indicated |
| MRI | May remain in place |
| Expected Infection Outcome | Resolution of signs and symptoms of local infection within approximately 2 weeks |
Biatain Silicone Ag is a silicone-bordered antimicrobial silver foam dressing designed for exuding wounds where local infection, biofilm, or increased infection risk requires antimicrobial wound management.
Its polyurethane foam and 3DFit Technology allow the dressing to conform closely to the wound bed while helping prevent exudate from pooling in dead space. A patented ionic silver complex provides sustained antimicrobial activity for up to 7 days, while the silicone border provides integrated dressing fixation.
Successful use depends on appropriate wound and exudate assessment, correct sizing, adequate wound-edge overlap, careful preparation of the periwound skin, monitoring of exudate progression, and reassessment if the dressing begins adhering to the wound bed.
Clinical Disclaimer: This article is intended for healthcare education and should be used alongside individualized clinical assessment, organizational wound-care protocols, and current manufacturer instructions for use. Consult an NSWOC, wound clinician, or other appropriate healthcare professional when additional wound-management guidance is required.
